<DOC>
	<DOCNO>NCT01541306</DOCNO>
	<brief_summary>Achondroplasia hypochondroplasia common form dwarfism . Recent study show small hormone call C-type natriuretic peptide ( CNP ) important regulator linear growth . The investigator believe genetic abnormality cause achondroplasia hypochondroplasia also disrupt CNP signal , may contribute growth problem . The investigator propose look level closely relate hormone child adult achondroplasia hypochondroplasia see different level healthy people . The investigator hypothesis CNP level elevate child achondroplasia hypochondroplasia , compare healthy population . Another hypothesis CNP level elevate adult achondroplasia hypochondroplasia , since adult growth-plate cartilage . By study potential role CNP system achondroplasia hypochondroplasia , investigator provide insight pathophysiology common syndrome , investigator also provide great insight regulation normal linear growth .</brief_summary>
	<brief_title>C-Type Natriuretic Peptide Achondroplasia</brief_title>
	<detailed_description>Achondroplasia common form dwarfism characterize short limb thighs upper arm affect . Achondroplasia also associate narrow foramen magnum spinal stenosis . Hypochondroplasia relate , less severe form dwarfism neurologic problem . Achondroplasia hypochondroplasia cause mutation fibroblast growth factor receptor-3 ( FGFR-3 ) gene cause constitutive activation receptor . FGFR-3 signal primarily MAP kinase pathway , overactivated growth plate chondrocytes achondroplasia . C-type natriuretic peptide ( CNP ) hormone produce act growth plate potent positive regulator linear growth . CNP signal natriuretic peptide receptor-B ( NPR-B ) , generate cGMP . Studies mice show activation MAP kinase pathway inhibits signal NPR-B . Hence achondroplasia phenotype may due part inhibition CNP signaling . Conversely , CNP intracellular signal inhibits MAP kinase pathway CNP analog study potential specific therapy achondroplasia . The objective project define state CNP system child adult achondroplasia hypochondroplasia . Our hypothesis 1 ) blood level CNP aminoterminal propeptide ( NTproCNP ) elevate blood level cGMP reduce child achondroplasia hypochondroplasia , due inhibition NPR-B ; 2 ) CNP NTproCNP level normal adult achondroplasia hypochondroplasia , due lack growth plate cartilage ; 3 ) healthy child , NTproCNP level predict height velocity child achondroplasia hypochondroplasia . These hypothesis address two specific aim . Specific aim 1 determine plasma level CNP , NTproCNP , cGMP child adult achondroplasia hypochondroplasia . Specific aim 2 determine NTproCNP level correlate height velocity child achondroplasia hypochondroplasia . The study observational , cross-sectional/partially longitudinal study child adult achondroplasia hypochondroplasia . Children see part routine clinic visit . Children see study period provide longitudinal data . Adult subject achondroplasia hypochondroplasia study single time . Data collect include anthropometrics , information neurologic complication achondroplasia , blood level CNP , NTproCNP , cGMP . We anticipate 100 subject recruit , 20 study many three time course study . By study potential role CNP system achondroplasia hypochondroplasia , provide insight pathophysiology common syndrome , also provide great insight regulation normal linear growth .</detailed_description>
	<mesh_term>Achondroplasia</mesh_term>
	<mesh_term>Natriuretic Peptide , C-Type</mesh_term>
	<criteria>diagnosis achondroplasia hypochondroplasia</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>C-type natriuretic peptide</keyword>
	<keyword>dwarfism</keyword>
	<keyword>growth</keyword>
	<keyword>achondroplasia</keyword>
	<keyword>hypochondroplasia</keyword>
	<keyword>biomarker</keyword>
</DOC>